SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsinin the development of laryngeal injury. Laryngoscope. 1991; 101: 1-78.
  • 2
    Freije JE, Beatty TW, Campbell BH, Woodson BH, Schultz CJ, Toohill RJ. Carcinoma of the larynx in patients with gastroesophageal reflux. Am J Otolaryngol. 1996; 17: 386-390.
  • 3
    Lippman SM, Hong WK. Chemotherapy and chemoprevention. In: MyersEN, SuenJY, editors. Cancer of the head and neck, 3rd ed. Philadelphia: W. B. Saunders Company, 1996: 782-804.
  • 4
    Winters C Jr. , Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987; 92: 118-24.
  • 5
    Postma GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol Suppl. 2000; 184: 10-14.
  • 6
    Little JP, Matthews BL, Glock MS, et al. WF. Extraesophageal pediatric reflux: 24-hour double-probe pH monitoring of 222 children. Ann Otol Rhinol Laryngol Suppl. 1997; 169: 1-16.
  • 7
    Walner DL, Stern Y, Gerber ME, Rudolph C, Baldwin CY, Cotton RT. Gastroesophageal reflux in patients with subglottic stenosis. Arch Otolaryngol Head Neck Surg. 1998; 124: 551-555.
  • 8
    Vincent DA, Garrett JD, Radionoff SL, Reussner LA, Stasney CR. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice. 2000; 14: 247-254.
  • 9
    Bove M, Ruth M, Cange L, Mansson I. 24-H pharyngeal pH monitoring in healthy volunteers: a normative study. Scand J Gastroenterol. 2000; 35: 234-241.
  • 10
    Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF, Mathus-Vliegen LM. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope. 2000; 110: 1007-1011.
  • 11
    Gaynor EB. Otolaryngologic manifestations of gastroesophageal reflux. Am J Gastroenterol. 1991; 86: 801-808.
  • 12
    Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340: 825-831.
  • 13
    Bain WM, Harrington JW, Thomas LE, Schaefer SD. Head and neck manifestations of gastroesophageal reflux. Laryngoscope. 1983; 93: 175-179.